Science

Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing Tactics

In early January, the U.S. House Committee on Energy and Commerce began investigating celebrity endorsements in television ads for brand-name drugs. The investigation was sparked by Pfizer's commercials for its best-selling cholesterol drug Lipitor. These direct-to-consumer (DTC) ads feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives.

Taking a Stand for Their Communities' Health

Low-income California communities concerned with environmental justice have launched a 21-point "Environmental Justice Movement Declaration." Their position is a challenge to the policies of Gov.

No

Smoldering Controversy

Smoking"Here's a recipe for academic controversy," observes Richard C. Paddock: "First, find dozens of hard-core teenage smokers as young as 14 and study their brains with high-tech scans. Second, feed vervet monkeys liquid nicotine and then kill at least six of them to examine their brains. Third, accept $6 million from tobacco giant Philip Morris to pay for it all.

No

U.S. Freezes Out Arctic Science

Scientists in eight Arctic nations prepared "a landmark assessment of oil and gas activity" in the region over six years, including "a clear set of recommendations on how to extract safely what are thought to be up to one quarter of the world's energy reserves." But the United States government blocked the report's release, as it prepares "to sell off exploration licenses for the frozen Chukchi Sea off Alaska, one of the last intact habitats of the polar bear." One of the authors of the report said the U.S. move "could be linked to activities in the Chukchi Sea ...

No

Seeking Protection for Whistleblowers That's Worth Its Salt

The case of Pierre Meneton is fueling demands for legal protections for whistleblowers in France. Meneton is a researcher for the National Institute of Health and the National Institute of Health and Medical Research. He is going to court on January 31, 2008, to face charges of defamation. Several industrial salt producers are suing Meneton for a comment he made during an interview in March 2006. "The lobbying of salt producers and agribusiness is very active.

No

Canada's Chalk River Nuclear Reactor Up and Running Again, but Safely?

Linda KeenLinda KeenThe fifty-year old nuclear reactor at Chalk River in Ontario, Canada, is running again after the Canadian Parliament overruled the president of the Canadian Nuclear Safety Commission.

No

Pages

Subscribe to Science